Abstract: Systems and methods for transferring data via a finger tracking smart device from a first user interface (“UI”) to a second UI is provided. The data transferred may be documentation data, including signatures and corrections. The finger tracking smart device may include one or more smart lenses. Methods may include triggering a tracking of the movement of the user's fingers on the first UI and further tracking a start point and an end point of the movement of the user's fingers based on detection of deliberate movements and gestures. Methods may further include capturing a segment of data within the start point of movement and the end point of movement and storing the segment of data in memory on the finger tracking smart device. Methods may further include updating the second UI based on an instruction in a data packet transmitted to the second UI, by inputting the segment of data at a point of movement of the user's fingers on the second UI.

Abstract: Systems and methods for predicting and preventing returns using transformative data-driven analytics and machine learning is provided. The systems and methods may include data stores to store and manage data within a network, as well as servers to facilitate operations using information from the one or more data stores. The systems and methods may also include an analytics subsystem having a data access interface to: receive data associated with a plurality of customers; and receive data associated with a plurality of transactions associated with the plurality of customers, where the plurality of transactions are transactions comprising at least a purchase, return, an exchange, or refund of an item.

Abstract: The invention relates to methods of modulating immune responses in a subject such as by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity, or which modulate the physical interaction between tim-1 and tim-4 or between tim-2 and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune disorders, transplantation tolerance, and Th1 and Th2-mediated responses and disorders. The invention also relates to novel assays for identifying agents which modulate the physical interaction between tim-1 and tim-4. In addition, the invention relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.

Abstract: The invention relates to methods of modulating immune responses in a subject, such as by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity, or which modulate the physical interaction between tim-1 and tim-4 or between tim-2 and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune disorders, transplantation tolerance, and Th1 and Th2-mediated responses and disorders. The invention also relates to novel assays for identifying agents which modulate the physical interaction between tim-1 and tim-4. In addition, the invention relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.

Abstract: The invention relates to methods of modulating immune responses in a subject, such as by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity, or which modulate the physical interaction between tim-1 and tim-4 or between tim-2 and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune disorders, transplantation tolerance, and Th1 and Th2-mediated responses and disorders. The invention also relates to novel assays for identifying agents which modulate the physical interaction between tim-1 and tim-4. In addition, the invention relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.